BACKGROUND: (1-3)-Beta-D-glucan is a fungal cell wall component, suspected to cause respiratory symptoms in adults. However, very little is known on the possible health effects of (1-3)-beta-D-glucan during infancy. We examined the association between (1-3)-beta-D-glucan exposure and the prevalence of allergen sensitization and wheezing during the first year of life in a birth cohort of 574 infants born to atopic parents. Endotoxin exposure was included as a possible confounder. METHODS: (1-3)-Beta-D-glucan and endotoxin exposures were measured in settled dust collected from infants' primary activity rooms. The primary outcomes at approximately age one included parental reports of recurrent wheezing and allergen sensitization evaluated by skin prick testing to a panel of 15 aeroallergens as well as milk and egg white. RESULTS: Exposure to high (1-3)-beta-D-glucan concentration (within fourth quartile) was associated with reduced likelihood of both recurrent wheezing [adjusted OR (aOR) = 0.39, 95% CI = 0.16-0.93] and recurrent wheezing combined with allergen sensitization (aOR = 0.13, 95% CI = 0.03-0.61). Similar trends were found between (1-3)-beta-D-glucan concentrations and allergen sensitization (aOR = 0.57, 95% CI = 0.30-1.10). In contrast, recurrent wheezing with or without allergen sensitization was positively associated with low (1-3)-beta-D-glucan exposure within the first quartile (aOR = 3.04, 95% CI = 1.25-7.38; aOR = 4.89, 95% CI = 1.02-23.57). There were no significant associations between endotoxin exposure and the studied health outcomes. CONCLUSIONS: This is the first study to report that indoor exposure to high levels of (1-3)-beta-D-glucan (concentration >60 microg/g) is associated with decreased risk for recurrent wheezing among infants born to atopic parents. This effect was more pronounced in the subgroup of allergen-sensitized infants.
BACKGROUND:(1-3)-Beta-D-glucan is a fungal cell wall component, suspected to cause respiratory symptoms in adults. However, very little is known on the possible health effects of (1-3)-beta-D-glucan during infancy. We examined the association between (1-3)-beta-D-glucan exposure and the prevalence of allergen sensitization and wheezing during the first year of life in a birth cohort of 574 infants born to atopic parents. Endotoxin exposure was included as a possible confounder. METHODS:(1-3)-Beta-D-glucan and endotoxin exposures were measured in settled dust collected from infants' primary activity rooms. The primary outcomes at approximately age one included parental reports of recurrent wheezing and allergen sensitization evaluated by skin prick testing to a panel of 15 aeroallergens as well as milk and egg white. RESULTS: Exposure to high (1-3)-beta-D-glucan concentration (within fourth quartile) was associated with reduced likelihood of both recurrent wheezing [adjusted OR (aOR) = 0.39, 95% CI = 0.16-0.93] and recurrent wheezing combined with allergen sensitization (aOR = 0.13, 95% CI = 0.03-0.61). Similar trends were found between (1-3)-beta-D-glucan concentrations and allergen sensitization (aOR = 0.57, 95% CI = 0.30-1.10). In contrast, recurrent wheezing with or without allergen sensitization was positively associated with low (1-3)-beta-D-glucan exposure within the first quartile (aOR = 3.04, 95% CI = 1.25-7.38; aOR = 4.89, 95% CI = 1.02-23.57). There were no significant associations between endotoxin exposure and the studied health outcomes. CONCLUSIONS: This is the first study to report that indoor exposure to high levels of (1-3)-beta-D-glucan (concentration >60 microg/g) is associated with decreased risk for recurrent wheezing among infants born to atopic parents. This effect was more pronounced in the subgroup of allergen-sensitized infants.
Authors: E von Mutius; C Braun-Fahrländer; R Schierl; J Riedler; S Ehlermann; S Maisch; M Waser; D Nowak Journal: Clin Exp Allergy Date: 2000-09 Impact factor: 5.018
Authors: J Douwes; A Zuidhof; G Doekes; S C van der Zee; I Wouters; M H Boezen; B Brunekreef Journal: Am J Respir Crit Care Med Date: 2000-10 Impact factor: 21.405
Authors: U Gehring; J Douwes; G Doekes; A Koch; W Bischof; B Fahlbusch; K Richter; H E Wichmann; J Heinrich Journal: Environ Health Perspect Date: 2001-02 Impact factor: 9.031
Authors: Sung Ho Hwang; Ik Mo Lee; Yun Keun Lee; Jeong Im Park; Kwang Won Rhie; Dong Uk Park; Chung Sik Yoon Journal: Environ Monit Assess Date: 2013-05-01 Impact factor: 2.513
Authors: Elisabet Johansson; Tiina Reponen; Stephen Vesper; Linda Levin; James Lockey; Patrick Ryan; David I Bernstein; Manuel Villareal; Gurjit K Khurana Hershey; Chris Schaffer; Grace Lemasters Journal: Environ Int Date: 2013-06-24 Impact factor: 9.621
Authors: B Behbod; J E Sordillo; E B Hoffman; S Datta; M L Muilenberg; J A Scott; G L Chew; T A E Platts-Mills; J Schwartz; H Burge; D R Gold Journal: Allergy Date: 2013-10-10 Impact factor: 13.146
Authors: Kathy T Schroer; Jocelyn M Biagini Myers; Patrick H Ryan; Grace K LeMasters; David I Bernstein; Manuel Villareal; James E Lockey; Tiina Reponen; Sergey Grinshpun; Gurjit K Khurana Hershey Journal: J Pediatr Date: 2008-10-31 Impact factor: 4.406